Syngene posts Rs 77.3 net profit in Q1FY22, gets boost from sales of COVID drug remdesivir

#Results, Syngene International

Syngene International on July 21 reported a year-on-year profit after tax of Rs 77.3 crore, a jump of 33 percent in Q1FY22 helped by COVID-19 antiviral medication Remdesivir.

The company reported Rs 58 crore profit in Q1FY21. Revenues rose 39 percent YoY to Rs 607 crore in Q1FY22 compared to Rs 437 crore in the corresponding period of the previous year.

The earnings before interest, tax, depreciation and amortisation (EBITDA) margins stood at 29 percent.

“We made a strong start to the financial year. Besides continuing progress across all our business divisions, growth for the quarter was strongly boosted by the manufacturing of COVID-19 treatment, Remdesivir, as we increased production to meet the needs of the second wave of COVID-19 in India,” said Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene.

“We also made headway with the expansion of our dedicated R&D centre for Bristol Myers Squibb following the contract extension announced last quarter,” Hunt added.

He said that the overall first-quarter performance was in line with its expectations and puts the company on track to meet its full-year growth guidance in the coming quarters.

Business Updates

During the quarter, the biologics business signed a five-year agreement with IAVI, a USA-based, non-profit, scientific research organisation, to develop and manufacture three recombinant, monoclonal antibodies (mAbs) for HIV.

“The mAbs will be used for phase I and II human clinical studies. Under the agreement, Syngene will provide an integrated solution including clone selection, analytical methods development, manufacturing process development, scale-up and cGMP manufacturing of drug substance, viral clearance studies, cGMP manufacturing of drug product and stability studies,” the company said.

Syngene said its scientists continued to work on the coronavirus and have generated several variants of the SARS-CoV2 spike S1 protein including the Alpha and Beta variants. These variants are used to determine the efficacy of different vaccines to cross-protect people from these strains.

John Shaw retires

John Shaw, non-independent director on the Board, and husband of Biocon’s Executive Chairperson Kiran Mazumdar-Shaw will retire due to health reasons, at the end of the 28th Annual General Meeting of the Company, scheduled on July 21.

“John was appointed to the Board in 2000 and has made significant contributions in helping the company cross many significant milestones. His strong management and financial experience helped Syngene establish the strong corporate governance that the company is recognized for,” Syngene said.

Dr Kush Parmar was appointed as a non-executive independent director on the Board effective June 22, 2021, subject to the approval of the shareholders at the AGM scheduled on July 21.

Dr Parmar, a Ph.D. in experimental pathology from Harvard University and an MD from Harvard Medical School, is currently the managing partner at 5AM Ventures, a life sciences venture capital firm headquartered in San Francisco.

Dr Parmar serves on the advisory boards of Harvard Medical School, Penn Medicine, Princeton University’s Department of Molecular Biology and the Grace Science Foundation. At Princeton University, Dr Parmar worked on developmental genetics with Nobel Laureate Eric F. Wieschaus. A founding member of the COVID-19 R&D alliance, Dr Parmar also serves on the Boards of Akouos, Entrada, Homology, Rallybio and Vor Biopharma.

News Related

OTHER NEWS

Realme to start export of India-made smartphones to Nepal from Q3

Realme is among the top four smartphone brands in markets like India, Czech Republic, and Greece. Tech major Realme on Monday said it will begin exporting India-made smartphones to Nepal ... Read more »

India says Johnson & Johnson withdraws proposal for speedy COVID-19 vaccine approval

Johnson & Johnson. | Representative Image (PC-Reuters) India’s drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without ... Read more »

Ambuja Cements to invest Rs 310 crore to expand Ropar unit in Punjab

Ambuja Cements, part of Swiss building material major Holcim group (Earlier LafargeHolcim) on Monday said it will invest Rs 310 crore to expand the production capacity of its plant at ... Read more »

PhonePe to provide UPI-based AutoPay feature for SIP investments

The PhonePe app (Representative image: Twitter/@PhonePe_) Digital payments platform PhonePe on August 2 said that it has introduced a Unified Payments Interface (UPI)-based AutoPay feature that will enable customers to set ... Read more »

Ahead of proposed IPO, Mini Ipe takes charge as LIC MD

Mini Ipe has taken charge as the managing director of Life Insurance Corporation of India (LIC) on August 2. This is ahead of the proposed initial public offering (IPO) of ... Read more »

Ashok Leyland sales up 81% at 8,650 units in July

Hinduja Group flagship firm Ashok Leyland on Monday reported 81 percent increase in total vehicle sales at 8,650 units in July. The company had sold 4,776 units in July 2020. ... Read more »

TVS Motor sales up 10% in July at 2,78,855 units

TVS Motor Company | The company reported profit at Rs 53.1 crore in Q1FY22 against loss of Rs 139.1 crore in Q1FY21, revenue jumped to Rs 3,934.4 crore from Rs ... Read more »

NCL Group wins Andhra Pradesh Govt contract worth Rs 1,863 crore

Entries for the competition are invited till August 15, 2021. A consortium of NCL Industries Ltd. and NCL Buildtek Ltd. has received Letters of Acceptance (LoA) of bids aggregating to ... Read more »

Brookfield-backed IndoStar Capital seeks time to meet minimum public shareholding norms

Source: ShutterStock IndoStar Capital Finance, a Mumbai-based non-banking finance company backed by Brookfield, has sought more time from the regulator to meet minimum public shareholding norms after missing a June ... Read more »

M&M posts nearly two-fold jump in passenger vehicle sales at 21,046 units in July

Mahindra & Mahindra Ltd on Monday reported a nearly two-fold jump in passenger vehicle sales at 21,046 units in July. The company had sold 11,025 units in the same month ... Read more »

Banking Central | The curious case of Videocon insolvency

The insolvency and bankruptcy code (IBC) faces yet another test as promoter Venugopal Dhoot has challenged the National Company Law Tribunal’s (NCLT’s) decision allowing Anil Agarwal’s Twin Star Technologies to take over ... Read more »

Bajaj Auto July sales jumps 44% in July

Bajaj Auto on Monday reported 44 percent jump in its total sales at 3,69,116 units in July 2021. The company had sold 2,55,832 units in the same month a year ... Read more »

Royal Enfield reports 9% rise in total sales to 44,038 units for July

Eicher Motors-controlled Royal Enfield posted 6 percent rise in domestic sales to 65,114 units during February as compared to 61,188 units sold in February last year. Exports of the company ... Read more »

Tata Motors sales up 92% to 51,981 units in July

Tata Motors (Representative image) Tata Motors said its total domestic sales increased by 92 percent to 51,981 units in July as compared to the same month last year. The company ... Read more »

Skoda sales surge over 3-folds in July at 3,080 units

Skoda Auto India reported over three-fold increase in sales in July at 3,080 units compared to 922 units in July 2020. The surge in sales is fuelled by the launch ... Read more »

Hyundai sales up 46% in July at 60,249 units

Source: Reuters Hyundai Motor India Ltd (HMIL) reported a 46 percent increase in total sales at 60,249 units in July. The company had sold 41,300 units in the same month ... Read more »

Nissan reports domestic sales of 4,259 units for July

Source: Reuters Automaker Nissan India on Sunday said its domestic sales rose to 4,259 units in July, up from 784 units in same month of last year. The company said ... Read more »

Maruti Suzuki reports 50% rise in July sales at 1,62,462 units

The country’s largest carmaker Maruti Suzuki India (MSI) reported a 50 percent increase in sales at 1,62,462 units in July. The company had sold 1,08,064 units in July last year, ... Read more »

Honda reports 12% rise in domestic sales at 6,055 units in July

Source: Reuters Honda Cars India Ltd (HCIL) on Sunday reported a 12 year-on-year rise in domestic sales at 6,055 units for July. The company had sold 5,383 units in the domestic ... Read more »

Adani floats company for petrochemical foray

Representative image Billionaire Gautam Adani’s ports-to-energy conglomerate has floated a new subsidiary that will set up refineries, petrochemical complexes and hydrogen plants – businesses that will directly compete with richest ... Read more »

MG Motor reports twofold jump in retail sales to 4,225 units for July

The logo of MG Motor is pictured at at the 37th Bangkok International Motor Show in Bangkok, Thailand, March 22, 2016. Picture taken March 22, 2016. REUTERS/Chaiwat Subprasom – GF10000356939 ... Read more »

HSBC restores interim dividend as second-quarter profit soars on reserve releases

HSBC, the biggest of the city’s three currency-issuing banks, said it would restore its interim dividend to shareholders as its second-quarter profit soared on releases of reserves for soured loans ... Read more »

Hero MotoCorp sales dip 13% in July

Hero MotoCorp The country’s largest two-wheeler maker Hero MotoCorp reported a 13 per cent dip in total sales at 4,54,398 units in July. The company had sold 5,20,104 units in ... Read more »

HDFC Life adopts calibrated approach on term policy sales, CEO says

Representative image HDFC Life Insurance is taking a calibrated approach on issuing term policies to keep costs under control and price risk better and has provided adequately for a possible ... Read more »

Relaxo Footwears Q1 up 27.8% to Rs 30.96 crore

Representative image. Relaxo Footwears Ltd on Saturday reported a 27.83 percent increase in net profit to Rs 30.96 crore in the quarter ended in June 2021. It had posted a ... Read more »

Bharti Airtel records identical subscriber fall of 1.3% in May across 26 telecom circles

(Source: Reuters) In what appears as more than a coincidence, all 26 telecom circles carrier  Bharti Airtel‘s showed an identical fall in subscribers at 1.3 percent in May over April this ... Read more »

Finolex Industries Q1 profit zooms to Rs 146 crore

Finolex Industries Ltd, integrated manufacturer of PVC pipes and fittings, has reported nearly three-fold jump in June quarter consolidated net profit at Rs 145.52 crore. The Pune-based company had posted ... Read more »

SBI waives processing fees on home loans till August 31

State bank of India Country’s largest lender, State Bank of India (SBI) on 31 July said the lender has waived the processing fees on home loans till August 31. There ... Read more »

Meet Mumbai-born Shailesh G Jejurikar, the newly appointed P&G global COO

Shailesh G Jejurikar Procter & Gamble has announced the appointment of Shailesh G Jejurikar as its global COO. This is the first-time an Indian has been given the role at the ... Read more »

Aditya Ghosh boards Akasa to make aviation comeback after three years

Akasa will mark Aditya Ghosh’s “return to the aviation industry” after his exit as President and whole time director of Indigo in 2018. (File Image) Aditya Ghosh is all set ... Read more »

No competition for KFC in India, says chairman of IPO-bound franchisee Devyani International

IPO-bound Devyani International, the biggest franchisee of Yum! Brands in India, sees no competition for KFC in the country, given its unique chicken offering, the company’s Chairman Ravi Kant Jaipuria ... Read more »

SC to hear next week Vedanta's plea to continue operating oxygen plant at Tuticorin

The Supreme Court Friday agreed to hear next week Vedanta’s plea seeking to continue operating its oxygen plant at Tuticorin beyond the July 31 deadline set by the top court. ... Read more »

Consumer durable firms expand digital efforts, says Emkay report

An allied area of focus for these companies is the increased emphasis on e-commerce and rural distribution. (Representative image) Consumer durable firms are expanding their digitisation efforts across internal and ... Read more »

Indian control clause dropped after changes in insurance law, says IRDAI

Insurance Regulatory and Development Authority of India (IRDAI) on July 30 said that the ‘Indian Control of an Indian Insurance Company’ and ‘Indian Ownership’ clause under insurance laws have been ... Read more »

Read the full text of Tata Motors Chairman N Chandrasekaran's speech at AGM

Tata Motors Chairman N N Chandrasekaran (File image: PTI) Tata Motors Chairman N Chandrasekharan, in his speech to the shareholders at the annual general meeting, highlighted the challenges faced by ... Read more »

Qualcomm optimistic on 5G, connected device sales as chip supply bottlenecks ease

Qualcomm Inc on Wednesday predicted a rise in sales of chips for 5G phones, including Apple’s iPhone, as the company said it had mitigated supply shortfalls that have contributed to ... Read more »

Hindustan Zinc to invest $1 billion to replace diesel vehicles with battery EVs

Hindustan Zinc Ltd. Mining major Hindustan Zinc Ltd will be investing about USD 1 billion (around Rs 7,440 crore) to replace diesel-run vehicles and equipment with battery electric vehicles across ... Read more »

ACME Solar Holdings raises $334 million via NCDs 

Representational Image. Photo : Jitendra Parihar (Thomson Reuters Foundation)/Flickr ACME Solar Holdings (ACME) on July 30 said it has raised $334 million via US dollar-denominated green bonds. The funds will ... Read more »

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

Lupin’s Australian subsidiary Generic Health on July 30 said it has entered into a definitive agreement to acquire 100 percent of the shares of privately-held Southern Cross Pharma Pty (SCP). ... Read more »

Eris Lifesciences on the lookout for acquisitions of brands, product portfolios

Eris Lifesciences Ltd. Ahmedabad-based drug maker Eris Lifesciences said it is on the lookout for acquiring brands and product portfolios. The company said it has shortlisted therapy segments such as ... Read more »